Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk

被引:228
作者
Liu, Xingguang [1 ,2 ]
Zhan, Zhenzhen [1 ,2 ]
Li, Dong [3 ]
Xu, Li [1 ,2 ]
Ma, Feng [3 ]
Zhang, Peng [1 ,2 ]
Yao, Hangping [3 ]
Cao, Xuetao [1 ,2 ,4 ]
机构
[1] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China
[2] Second Mil Med Univ, Inst Immunol, Shanghai, Peoples R China
[3] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China
[4] Chinese Acad Med Sci, Beijing 100037, Peoples R China
基金
中国国家自然科学基金;
关键词
BRUTONS TYROSINE KINASE; MAJOR HISTOCOMPATIBILITY COMPLEX; TUMOR-NECROSIS-FACTOR; RECEPTOR; EXPRESSION; CYTOKINE; BINDING; DOMAIN; CD40; PHOSPHORYLATION;
D O I
10.1038/ni.2015
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The molecular mechanisms involved in the full activation of innate immunity achieved through Toll-like receptors (TLRs) remain to be fully elucidated. In addition to their classical antigen-presenting function, major histocompatibility complex (MHC) class II molecules might mediate reverse signaling. Here we report that deficiency in MHC class II attenuated the TLR-triggered production of proinflammatory cytokines and type I interferon in macrophages and dendritic cells, which protected mice from endotoxin shock. Intracellular MHC class II molecules interacted with the tyrosine kinase Btk via the costimulatory molecule CD40 and maintained Btk activation, but cell surface MHC class II molecules did not. Then, Btk interacted with the adaptor molecules MyD88 and TRIF and thereby promoted TLR signaling. Therefore, intracellular MHC class II molecules can act as adaptors, promoting full activation of TLR-triggered innate immune responses.
引用
收藏
页码:416 / U71
页数:10
相关论文
共 51 条
[1]   MHC class II signaling in antigen-presenting cells [J].
Al-Daccak, R ;
Mooney, N ;
Charron, D .
CURRENT OPINION IN IMMUNOLOGY, 2004, 16 (01) :108-113
[2]   Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1 [J].
An, Huazhang ;
Hou, Jin ;
Zhou, Jun ;
Zhao, Wei ;
Xu, Hongmei ;
Zheng, Yuejuan ;
Yu, Yizhi ;
Liu, Shuxun ;
Cao, Xuetao .
NATURE IMMUNOLOGY, 2008, 9 (05) :542-550
[3]   EXPERIMENTAL AND CLINICAL-SIGNIFICANCE OF ENDOTOXIN-DEPENDENT HLA-DR EXPRESSION ON MONOCYTES [J].
APPEL, SH ;
WELLHAUSEN, SR ;
MONTGOMERY, R ;
DEWEESE, RC ;
POLK, HC .
JOURNAL OF SURGICAL RESEARCH, 1989, 47 (01) :39-44
[4]   Monocyte response to bacterial toxins, expression of cell surface receptors, and release of anti-inflammatory cytokines during sepsis [J].
Astiz, M ;
Saha, D ;
Lustbader, D ;
Lin, R ;
Rackow, E .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1996, 128 (06) :594-600
[5]   Toll-like receptor signaling pathways [J].
Barton, GM ;
Medzhitov, R .
SCIENCE, 2003, 300 (5625) :1524-1525
[6]  
Beharka AA, 1998, IN VITRO CELL DEV-AN, V34, P499
[7]  
BISHOP GA, 1991, J IMMUNOL, V147, P1107
[8]   THE LOW-AFFINITY RECEPTOR FOR IGE (CD23) ON LYMPHOCYTES-B IS SPATIALLY ASSOCIATED WITH HLA-DR ANTIGENS [J].
BONNEFOY, JY ;
GUILLOT, O ;
SPITS, H ;
BLANCHARD, D ;
ISHIZAKA, K ;
BANCHEREAU, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (01) :57-72
[9]  
BRADBURY LE, 1992, J IMMUNOL, V149, P2841
[10]   Bruton's tyrosine kinase is activated upon CD40 stimulation in human B lymphocytes [J].
Brunner, C ;
Avots, A ;
Kreth, HW ;
Serfling, E ;
Schuster, V .
IMMUNOBIOLOGY, 2002, 206 (04) :432-440